Cargando…

Recombinant DNA human interferon alpha 2 in advanced breast cancer: a phase 2 trial.

Effectiveness of recombinant DNA (rDNA) human interferon alpha 2 (IFN alpha 2) in advanced breast cancer was evaluated in 14 patients who had received prior endocrine and/or cytotoxic therapy. After randomization, 7 patients received IFN alpha 2 two million IU m-2 day-1, s.c., 3 times a week (schedu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padmanabhan, N., Balkwill, F. R., Bodmer, J. G., Rubens, R. D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1985
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976812/ https://www.ncbi.nlm.nih.gov/pubmed/3917678

Ejemplares similares

EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary Group.
por: De Mulder, P. H., et al.
Publicado: (1995)

Recombinant interferon in advanced breast cancer.
por: Nethersell, A., et al.
Publicado: (1984)

A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.
por: Jayson, G. C., et al.
Publicado: (1998)

A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
por: Piga, A., et al.
Publicado: (1996)

Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension
por: Bauer, Eileen M., et al.
Publicado: (2014)

Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
por: Gull, Iram, et al.
Publicado: (2013)

Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia
por: Ghaffari, Reza, et al.
Publicado: (2021)

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.
por: Lai, C. L., et al.
Publicado: (1989)

Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity.
por: Tank, B., et al.
Publicado: (1984)

Intraventricular recombinant alpha-interferon in subacute sclerosing panencephalitis
por: Cianchetti, C., et al.
Publicado: (1991)

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
por: Biesma, B., et al.
Publicado: (1992)

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.
por: Ravaud, A., et al.
Publicado: (1994)

Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.
por: Bernhard, H., et al.
Publicado: (1995)

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1990)

Evaluation of Adverse Effects of Mutein Forms of Recombinant Human Interferon Alpha-2b in Female Swiss Webster Mice
por: Rachmawati, H., et al.
Publicado: (2013)

The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
por: Bergsagel, D. E., et al.
Publicado: (1990)

Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies
por: Ali Khan, Wahid
Publicado: (2018)

Effect of recombinant human interferon-alpha in vitro and in vivo on mitogen-induced lymphocyte blastogenesis in cats()
por: Weiss, R.C., et al.
Publicado: (1990)

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1992)

Intratumoral recombinant human interferon alpha‐2a and vincristine combination therapy in canine transmissible venereal tumour
por: Kanca, Halit, et al.
Publicado: (2018)

Human interferons inhibit experimental metastases of a human melanoma cell line in nude mice.
por: Ramani, P., et al.
Publicado: (1988)

Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee.
por: Rubens, R. D., et al.
Publicado: (1991)

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.
por: Johnston, S. R., et al.
Publicado: (1998)

Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanoma.
por: Kruit, W. H., et al.
Publicado: (1995)

Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinoma.
por: Ferguson, J. E., et al.
Publicado: (1995)

Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.
por: Pichert, G., et al.
Publicado: (1990)

Acute and Sub-chronic Toxicity Study of Recombinant Bovine Interferon Alpha in Rodents
por: Yu, Hai-Yang, et al.
Publicado: (2021)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
por: Wittling, Megen C., et al.
Publicado: (2021)

Anti-Interferon Alpha Antibodies in Patients with High-Risk BCR/ABL-Negative Myeloproliferative Neoplasms Treated with Recombinant Human Interferon-α
por: Aruna,, et al.
Publicado: (2018)

Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy.
por: von Rohr, A., et al.
Publicado: (1993)

Immune human lymphocytes produce an acid-labile α-interferon
por: Balkwill, FR, et al.
Publicado: (1983)

Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer.
por: Goey, S. H., et al.
Publicado: (1996)

Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen.
por: van den Berg, H. W., et al.
Publicado: (1987)

Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects
por: Yi, Taolin, et al.
Publicado: (2011)

Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2 alpha.
por: Reid, I., et al.
Publicado: (1991)

Electrostatics Drive Oligomerization and Aggregation of Human Interferon Alpha-2a
por: Pohl, Christin, et al.
Publicado: (2021)

Bilateral Retrobulbar Optic Neuropathy in the Setting of Interferon Alpha-2a Therapy
por: Fuzzard, Dujon R.W., et al.
Publicado: (2014)

Alveolar soft-part sarcoma responding to interferon alpha-2b
por: Roozendaal, K J, et al.
Publicado: (2003)

Subcutaneous administration of interleukin 2 and interferon-alpha-2b in advanced renal cell carcinoma: a confirmatory study.
por: Facendola, G., et al.
Publicado: (1995)

Potentiation of Antitumor Activity of Macrophages by Recombinant Interferon Alpha A/D Contained in Gelatin Microspheres
por: Tabata, Yasuhiko, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_ij1nvk2jenu7b6lcuoioju5mpr